Body Handbook Catalogue Profile Ranking
Supplements BODY HANDBOOK
Supplements Β· Β§549
SAM-e (S-Adenosylmethionine)
SAM-e is the supplement your liver already makes, sold as a prescription drug across Europe and as tablets in the American supplement aisle. The bottle promises a broad mood-and-energy lift, and that broad promise is where it fails: the real evidence is narrow. It earns its place in two spots only β€” as the second move when a working antidepressant has stalled, and as a swap for the daily anti-inflammatory pill your stomach can no longer take. Outside those two lanes, it does little.
Do Β· Daily Evidence Mixed Chapter Supplements

What it is. A methyl donor: the molecule your cells use to tag DNA, build neurotransmitters, and patch membranes. You make it from methionine, and usually you make plenty 1. Supplementing is a bet that in certain slumps the supply runs short and adding more gets things moving.

Depression is the strongest case, and only as an add-on. In stalled patients who added SAM-e on top of an SSRI or SNRI, about a third improved versus a sixth on placebo, and a quarter reached remission versus a ninth 2. A later trial pointed the same way, weaker 3. As a stand-alone replacement, it flops: a Cochrane review saw no clear separation from placebo 4, and a monotherapy trial confirmed the null 5.

Joints are the second case. SAM-e matched ibuprofen, naproxen, and celecoxib on arthritic pain and function by month two, with a gentler gut 6. The honest catch: against placebo directly the pain gap was about four millimetres on a ten-centimetre scale, too small to feel 7. So it's as good as an anti-inflammatory pill, which is itself only modestly better than placebo, and much slower. Worth it mainly if your stomach can no longer tolerate the daily ibuprofen.

If you're going to try it, the dose is the whole game. Shelf-standard 200 mg and 400 mg tablets deliver a quarter of what worked in trials. The dose that did anything was 1200 to 1600 mg a day, split.

Weigh it against the standards first. For depression, SSRIs, therapy, aerobic exercise, and morning light all beat SAM-e as a first move; SAM-e's slot is the second one, after a partial response stalls 2. For joints, topical diclofenac gel gives most of the benefit with a fraction of the stomach risk, and exercise plus weight loss outperforms the pills over a year.

The fine print β€” when to skip it, and what people get wrong

Bipolar disorder: SAM-e can trigger mania like any antidepressant, so keep it clinician-supervised 9. Don't combine with MAO inhibitors, don't add it to your own SSRI without telling your prescriber, and know it may blunt levodopa for Parkinson's.

Most people who feel nothing under-dosed (one 400 mg tablet is a quarter of the working amount), took it with breakfast (food roughly halves absorption 8), or used it for ordinary low mood the trials never tested.

References
  1. 1Bottiglieri T (2002). S-Adenosyl-L-methionine (SAMe): from the bench to the bedsideβ€”molecular basis of a pleiotrophic molecule. American Journal of Clinical Nutrition. link
  2. 2Papakostas et al. (2010). S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial. American Journal of Psychiatry. link
  3. 3Sarris et al. (2018). Adjunctive S-adenosylmethionine (SAMe) in treating non-remittent major depressive disorder: an 8-week double-blind, randomized, controlled trial. European Neuropsychopharmacology. link
  4. 4Galizia et al. (2016). S-adenosyl methionine (SAMe) for depression in adults. Cochrane Database of Systematic Reviews. link
  5. 5Sarris et al. (2020). S-Adenosylmethionine (SAMe) monotherapy for depression: an 8-week double-blind, randomised, controlled trial. Psychopharmacology. link
  6. 6Najm et al. (2004). S-adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: a double-blind cross-over trial. BMC Musculoskeletal Disorders. link
  7. 7Rutjes et al. (2009). S-Adenosylmethionine for osteoarthritis of the knee or hip. Cochrane Database of Systematic Reviews. link
  8. 8Aliani et al. (2020). Pharmacokinetic study of a novel oral formulation of S-adenosylmethionine (MSI-195) in healthy subjects: dose escalation, food effect and comparison to a commercial nutritional supplement product. BMC Pharmacology and Toxicology. link
  9. 9Mischoulon D, Fava M (2002). Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence. American Journal of Clinical Nutrition. link
Β·
549